drugset / Trial / NCT03760042
Study To Assess Local Tolerability of Crisaborole 2% Ointment and Vehicle Ointment In Healthy Participants Using Subject-reported Assessments and Objective Measurements
RandomizedParallel-groupTriple-blindOther
Summary
A double-blind within-subject study to estimate observed application site adverse events following topical applications of crisaborole and vehicle in healthy participants
Timeline
- Start
- 2018-11-14
- Primary completion
- 2019-04-15
- Completion
- 2019-04-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Crisaborole | Small molecule | 2 % | Topical |
Indications
No indication recorded.